Trade Summary

6 days ago, Encrantz Staffan, serving as Dir at Sight Sciences, Inc. (SGHT), purchased 14,100 shares at $4.88 per share, for a total transaction value of $68,793.90. Following this transaction, Encrantz Staffan now holds 1,434,283 shares of SGHT.

This purchase represents a 0.99% increase in Encrantz Staffan's stake in the company.

The trade was executed on Wednesday, June 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 at 4:43 PM ET, 1 day after the trade was made.

Sight Sciences, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.